In a statement, the archdiocese said the 71-year-old cardinal has “well-differentiated liposarcoma, which is a non-aggressive ...

Cardinal Robert McElroy plans to be back at work in Washington two weeks after his surgery, scheduled for Nov. 13.

According to the statement, Cardinal McElroy’s cancer will be surgically removed on Nov. 13, and his doctors 'are in ...

Cardinal Robert McElroy, the former bishop of San Diego, is set to undergo surgery after he was diagnosed with cancer, the ...

He said he hopes and believes "that in God's grace I will be Archbishop of Washington for many years to come." ...

Cardinal Robert McElroy, the Archbishop of Washington, will soon undergo surgery to remove 'non-agressive' cancer cells, ...

Cardinal Robert McElroy, the eighth Archbishop of Washington, has been diagnosed with liposarcoma, and he will have the cancer surgically removed on Nov. 13, the Archdiocese of Washington said in an ...

DelveInsight's Liposarcoma Market Insights report includes a comprehensive understanding of current treatment practices, liposarcoma emerging drugs, market share of individual therapies, and current ...

New York, USA, May 27, 2025 (GLOBE NEWSWIRE) -- Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The liposarcoma treatment ...

Liposarcomas are a rare type of malignancy with a very heterogeneous morphological appearance and clinical course. The therapeutic approach is based on histopathological classification and is ...

Benign: Not cancerous; does not invade nearby tissue or spread to other parts of the body. CT scan-A test using computers and X-rays to create images of various parts of the body. DNA: The ...

In the past, clinical studies of soft tissue sarcoma have tended to recruit patients with all histologic subtypes, in part because of the rarity of the disease. Not surprisingly, these trials were ...